TickerLeague

Gross Profit for Revolution Medicines (RVMD)

According to Revolution Medicines's latest reported financial statements, the company's current gross profit (TTM) is -$9.24M USD. Gross profit equals revenue minus the cost of goods sold (COGS) — what remains from sales after the direct cost of producing the product or service. It does not yet subtract operating expenses, interest, or taxes (see operating income and net income for those steps). Higher gross profit (and gross margin) generally signals pricing power and production efficiency.

Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .

TTM (last 4 quarters)

-$9.24M

YoY change

N/A

5Y CAGR

N/A

Peak year (2019)

$50.04M

Cumulative gross profit

$146.40M

Gross Profit history chart for Revolution Medicines (RVMD) from 2017 to 2025

Gross Profit history table for Revolution Medicines (RVMD) from 2017 to 2025

Fiscal yearPeriod endedReportedGross ProfitYoYYoY change
2025-$16.56M-$16.56M
2024$0-100.0%-$11.58M
2023$11.58M-67.3%-$23.80M
2022$35.38M+20.4%+$5.99M
2021$29.39M-31.6%-$13.59M
2020$42.98M-14.1%-$7.06M
2019$50.04M+148.2%+$29.88M
2018$20.16M-175.8%+$46.75M
2017-$26.59M

Gross Profit values are taken from Revolution Medicines's reported income statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.

Analysis

2025's annual gross profit for Revolution Medicines (RVMD) came in at -$16.56M.

Revolution Medicines gross profit plunged from $50.04M in 2019 to -$16.56M in 2025, a 133.1% drawdown.

The dataset's maximum gross profit sits at $50.04M (2019); the minimum reading of -$26.59M dates to 2017.

Revolution Medicines (RVMD) sits 9th of 8 Healthcare peers we track on this metric, against a peer median of $51.36B.

Revolution Medicines Gross Profit by Year

Revolution Medicines Gross Profit 2025: -$16.56M

Revolution Medicines gross profit in 2025 was -$16.56M.

Revolution Medicines Gross Profit 2024: $0

Revolution Medicines gross profit in 2024 was $0, plunged 100.0% below 2023.

Revolution Medicines Gross Profit 2023: $11.58M

Revolution Medicines gross profit in 2023 was $11.58M, plunged 67.3% below 2022.

Revolution Medicines Gross Profit 2022: $35.38M

Revolution Medicines gross profit in 2022 was $35.38M, grew 20.4% from 2021.

Revolution Medicines Gross Profit 2021: $29.39M

Revolution Medicines gross profit in 2021 was $29.39M.

See more financial history for Revolution Medicines (RVMD).

Sector peers — Gross Profit

Companies in the same sector as Revolution Medicines, ranked by their latest gross profit.

CompanyGross ProfitSector
Novo Nordisk (NVO)$250.28BHealthcare
UnitedHealth Group (UNH)$82.92BHealthcare
Johnson & Johnson (JNJ)$68.56BHealthcare
Eli Lilly (LLY)$54.62BHealthcare
AstraZeneca (AZN)$48.11BHealthcare
Merck & Co. (MRK)$46.73BHealthcare
AbbVie (ABBV)$42.96BHealthcare
Amgen (AMGN)$26.01BHealthcare

Frequently asked questions

What is Revolution Medicines's gross profit?

Latest reported gross profit for Revolution Medicines (RVMD) is -$9.24M (period ending March 31, 2026).

When did Revolution Medicines gross profit hit its highest annual value?

Revolution Medicines gross profit reached its highest annual value of $50.04M in 2019.

What was Revolution Medicines gross profit in 2024?

Revolution Medicines (RVMD) gross profit in 2024 was $0.

What was Revolution Medicines gross profit in 2025?

Revolution Medicines (RVMD) gross profit in 2025 was -$16.56M.

RVMD Key Financials

Pick a metric for charts, filings and peers — each row shows the latest TTM or most-recent-quarter value.